Gossamer Bio, Inc.

NASDAQ:GOSS

Biotechnology

Healthcare
$11.04 +3.24%

+$0.01 today

Market cap
$67.52M
Beta
2.04
P/E (TTM)
-0.2
EPS (TTM)
-$0.77
52W Low $0.11High $3.87

Volume 0.22M

Average 19.76M

Price history

Gossamer Bio, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+261.97%

Period high

$11.94

Period low

$0.14

Latest

$11.04

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 10, 2026Nov 10, 2026
8-KNov 10, 2026Nov 10, 2026
SC 13G/ANov 6, 2026Nov 6, 2026
SC 13GNov 6, 2026Nov 6, 2026
SC 13D/AOct 29, 2026Oct 29, 2026
8-KOct 28, 2026Oct 28, 2026
SC 13D/AOct 8, 2026Oct 8, 2026
8-KSep 28, 2026Sep 28, 2026
SC 13D/ASep 28, 2026Sep 28, 2026
4Sep 25, 2026Sep 25, 2026
4Sep 25, 2026Sep 25, 2026
4Sep 25, 2026Sep 25, 2026
4Sep 25, 2026Sep 25, 2026
4Sep 25, 2026Sep 25, 2026
4Sep 25, 2026Sep 25, 2026

Competitors

Who does Gossamer Bio, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about GOSS's filings, answered from its disclosures.

What is the latest GOSS filing?

The latest filing shown is 10-Q dated Nov 10, 2026.

How many recent filings does GOSS have?

Intrinsic Alpha currently shows 20 recent filings for GOSS.